© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 23.59% of CUE shares are held by financial institutions. JPMORGAN CHASE & CO is the top corporate investor, holding 15.43K shares valued at $29.16K. A 0.03% stake in Cue Biopharma, Inc. is owned by the company. SUNBELT SECURITIES, INC. owns 237 shares valued at $448.00, which translates its holding of 0% of the stake in the company.
Among the CUE insiders holding of 0.55% of the stake in company, , , holds the largest shares of -. , , is the second largest CUE insider with ownership of - shares. , , stands third with possession of - shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CUE shares is 69, representing 23.59% of the company's common stock.
JPMORGAN CHASE & CO, in the last quarter, reduced its stake in CUE by -31.26% restricting it's holding to 15.43 thousand shares of worth nearly $29.16K. DIMENSIONAL FUND ADVISORS LP also lessened -5.82% of the CUE shares from its portfolio, reducing its holding to 431.31 thousand shares of worth $815.17K. NORTHERN TRUST CORP also shunned CUE shares holding by -4.24% last quarter which brought its holding to 365.18 thousand shares worth $690.20K.
As per its latest 13F filing, MILLENNIUM MANAGEMENT LLC increased its stake in CUE by 31.36% in the last quarter. The institutional holder raised its holding to 362.09 thousand shares having worth more than $684.35K. RENAISSANCE TECHNOLOGIES LLC also added 214.26% more shares of CUE to its portfolio, raising its holding to 274.03 thousand shares of worth $518.00K. SIGMA PLANNING CORP also increased its CUE shares holding by 135.14% which brought its holding to 256.01 thousand shares worth $483.85K.
The insider with the most stakes in CUE is N/A , N/A at the company. Additionally, CUE stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own 0.55% percent of Cue Biopharma, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CUE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include KIENER PETER A, SURI ANISH, and MILLAR KERRI-ANN.
There have been 1 transaction(s) during the past 6-months in which Cue Biopharma, Inc. insiders have bought stock, totalling 30000 shares
Around 164.58K Cue Biopharma, Inc. shares are held by insiders, which represents about 0.55% of CUE stock.
CUE N/A, N/A holds the largest portfolio of the company's shares. CUE shares owned by N/A total nearly -.
JPMORGAN CHASE & CO is the largest institutional owner in CUE which holds 15.43 thousand shares worth $29.16K or 0.03% of the total CUE shares outstanding followed by SUNBELT SECURITIES, INC. with ownership of 237 shares representing 0% of the CUE ownership. ARMSTRONG ADVISORY GROUP, INC is the third largest stakeholder with 120 shares or 0% of the ownership worth more than $317.00.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CUE is concerned, it is a stock which is optionable.
Number of CUE shares short is 1.95M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 60.21M shares of CUE are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CUE has 48.24M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CUE is 1.99.